Dexamethasone for the Prophylaxis of Radiation-induced Pain Flare after Palliative Radiotherapy for Symptomatic Bone Metastases: a Phase II Study

Clinical Oncology

Volumn 21, Issue 4, 2009, Pages 329-335

  Hird, A ^a   Zhang, L ^a   Holt, T ^b   Fairchild, A ^c   DeAngelis, C ^a   Loblaw, A ^a   Wong, R ^d   Barnes, E ^a   Tsao, M ^a   Danjoux, C ^a   Chow, E ^a  

^a DEPARTMENT OF RADIATION ONCOLOGY   (Canada)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c CROSS CANCER INSTITUTE   (Canada)

^d PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

Bone metastases; dexamethasone; flare; palliative radiotherapy; prophylaxis

Indexed keywords

ANALGESIC AGENT; DEXAMETHASONE;

ADULT; AGED; ARTICLE; BONE METASTASIS; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PAIN ASSESSMENT; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIATION DOSE; RADIATION INDUCED PAIN FLARE; RADIATION INJURY; RATING SCALE; SCORING SYSTEM; SINGLE DRUG DOSE; SYMPTOMATOLOGY;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS, HORMONAL; BONE NEOPLASMS; DEXAMETHASONE; DISEASE PROGRESSION; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PAIN; PALLIATIVE CARE; QUALITY OF LIFE; RADIOTHERAPY, ADJUVANT;

EID: 62949118214     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clon.2008.12.010     Document Type: Article

References (23)

1. InSightec.com: pain palliation of bone metastases - overview. http://www.insightec.com/135-en-r10/BoneMetastases.aspx Accessed May 2008
2. Chow E., Wong R., Hruby G., et al. Prospective patient-based assessment of effectiveness of palliative radiotherapy for bone metastases in an outpatient radiotherapy clinic. Radiother Oncol 61 (2001) 77-82
3. Nielsen O.S. Palliative radiotherapy of bone metastases: there is now evidence for the use of single fractions. Radiother Oncol 52 (1999) 95-96
4. Berk L. Prospective trials for the radiotherapeutic treatment of bone metastases. Am J Hosp Palliat Care 12 (1995) 24-28
5. Arcangeli G., Giovinazzo G., Saracino B., et al. Radiation therapy in the management of symptomatic bone metastases: the effect of total dose and histology on pain relief and response duration. Int J Radiat Oncol Biol Phys 42 (1998) 1119-1126
6. Chow E., Harris K., Fan G., et al. Palliative radiotherapy trials for bone metastases: a systematic review. J Clin Oncol 25 (2007) 1423-1436
7. Sze W.M., Shelley M., Held I., and Mason M. Palliation of metastatic bone pain: single fraction versus multifraction radiotherapy - a systemic review of randomized trials. Clin Oncol 15 (2003) 345-352
8. Wu J.S.Y., Wong R., Johnston M., et al. Meta-analysis of dose-fractionation radiotherapy trials for the palliation of painful bone metastases. Int J Radiat Oncol Biol Phys 55 (2006) 594-605
9. Kirkbride P., and Aslanidis J. Single fraction radiation therapy for bone metastases - a pilot study using a dose of 12 Gy. Clin Invest Med 19 Suppl. (1996) 87s (abstract 581)
10. Foro P., Algara M., Reig A., et al. Randomized prospective trial comparing three schedules of palliative radiotherapy. Preliminary results. Oncologia 21 (1998) 55-60 (in Spanish)
11. Loblaw D.A., Wu J.S.Y., Warde P., et al. Pain flare in patients with bone metastases after palliative radiotherapy: a nested randomized controlled trial. Support Care Cancer 15 (2007) 451-455
12. Chow E., Ling A., Davis L., et al. Pain flare following external beam radiotherapy and meaningful change in pain scores in the treatment of bone metastases. Radiother Oncol 75 (2005) 64-69
13. Roos D.E., Turner S.L., O'Brien P.C., et al. Randomized trial of 8 Gy in 1 versus 20 Gy in 5 fractions of radiotherapy for neuropathic pain due to bone metastases (Trans-Tasman Radiation Oncology Group, TROG 96.05). Radiother Oncol 75 (2005) 54-63
14. Hird A., Hadi S., Loblaw A., et al. Pain flare following radiotherapy for painful bone metastases: a joint effort of three cancer centres to determine the incidence. Int J Radiat Oncol Biol Phys 69 Suppl. (2006) 32s-33s (abstract 57)
15. Kirkbride P.A., Bezjak A., Pater J., et al. Dexamethasone for the prophylaxis for radiation-induced emesis: a National Cancer Institute of Canada Clinical Trials Group phase III study. J Clin Oncol 18 (2000) 1960-1966
16. Hempen C., Weiss E., and Hess C.F. Dexamethasone treatment in patients with brain metastases and primary brain tumors: do the benefits outweigh the side-effects?. Support Care Cancer 10 (2002) 322-328
17. Chow E., Loblaw D.A., Harris K., et al. Dexamethasone for the prophylaxis of radiation-induced pain flare after palliative radiotherapy for bone metastases - a pilot study. Support Care Cancer 15 (2007) 643-664
18. Cleeland C.S., and Ryan K.M. Pain assessment: global use of the Brief Pain Inventory. Ann Acad Med Singapore 23 (1994) 129-138
19. Aaronson N.K., Ahmedzai S., Bergman B., et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85 (1993) 365-376
20. Harris K., Li K., Flynn C., and Chow E. Worst, average or current pain in the brief pain inventory: which should be used to calculate the response to palliative radiotherapy in patients with bone metastases?. Clin Oncol 19 (2007) 523-527
21. Li K.K., Hadi S., Kirou-Mauro A., and Chow E. When should we define the response rates in the treatment of bone metastases by palliative radiotherapy?. Clin Oncol 20 (2008) 83-89
22. Chow E., Wu J., Hoskin P., et al. on behalf of the International Bone Metastases Consensus Working Party. International consensus on palliative radiotherapy endpoints for future clinical trials in bone metastases. Radiother Oncol 64 (2002) 75-280
23. McCune J.S., Hawke R.L., LeCluyse E.L., et al. In vivo and in vitro induction of human cytochrome P4503A4 by dexamethasone. Clin Pharmacol Ther 68 (2000) 356-366